Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Myeloid 1Classical hematology 1CNS 1

Conditions

Brain Neoplasms 8Seizures 6Leukemia, Myeloid, Acute 3Glioma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Glioblastoma 2Central Nervous System Neoplasms 2beta-Thalassemia 1Postoperative Seizures After Brain Tumor Surgery 1Pinealoma 1Oligodendroglioma 1Neurofibromatosis 1 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasm, Residual 1Necrosis 1Myelodysplastic Syndromes 1Meningioma 1Medulloblastoma 1Leukemia, Myelomonocytic, Juvenile 1Influenza, Human 1Hematologic Neoplasms 1Gliosarcoma 1Epilepsy 1Ependymoma 1Chromosome Aberrations 1Chromosome 7, monosomy 1Astrocytoma 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 328Methotrexate 182Cytarabine 164fludarabine phosphate 151Vincristine 128Dexamethasone 126fludarabine 123Peripheral Blood Stem Cell Transplantation 116Whole-Body Irradiation 108Etoposide 106Mycophenolic Acid 105Tacrolimus 95Busulfan 95Filgrastim 93Melphalan 81Cyclosporine 80Rituximab 79Doxorubicin 79Mercaptopurine 70Radiotherapy 62Antilymphocyte Serum 62Prednisone 57Granulocyte Colony-Stimulating Factor 57blinatumomab 55pegaspargase 54Asparaginase 54Thiotepa 52Daunorubicin 52Calcium Dobesilate 47Clofarabine 45

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Levetiracetam × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT01685411 2021-04-13

Busulfan and Cyclophosphamide Followed By ALLO BMT

Masonic Cancer Center, University of Minnesota

Phase NA Terminated
5 enrolled 16 charts
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡